Breast MRI Screening: When Is It Recommended?

What is breast MRI screening?

MRI stands for magnetic resonance imaging. A breast MRI uses a strong magnet and radio waves, rather than X-rays, to build very detailed pictures of the inside of your breasts. You lie face down on a padded table with your breasts resting in a hollow, and the table slides into a tunnel-shaped scanner. Most breast MRI scans also use a special dye, called a contrast agent, given through a small needle in your arm. This helps any unusual areas show up more clearly.

MRI is not used for routine breast screening of the general population. According to the NHS, the standard breast screening programme uses mammograms (breast X-rays), not MRI. Breast MRI is an extra, more sensitive test reserved for women who have a higher-than-average chance of developing breast cancer, where a mammogram on its own may not be enough.

This page gives general, educational information. It is not personal medical advice. If you are worried about your risk of breast cancer, or you are not sure whether you should be having extra screening, please speak to your GP or breast care team, who can look at your own family history and circumstances.

How MRI differs from a mammogram

Mammograms are the backbone of breast screening in the UK, and for most women they work very well. But they have limits. They use X-rays, and in some women, particularly younger women and those with dense breast tissue, cancers can be harder to spot on a mammogram. MRI works in a completely different way and is more sensitive, meaning it is more likely to pick up a cancer that is present. This is why it is the preferred test for certain higher-risk groups.

According to NICE, studies in high-risk women have found MRI to be considerably more sensitive at detecting breast cancer than mammography, and its accuracy is not reduced by younger age or by dense breast tissue in the way a mammogram's can be. That is a key reason MRI is offered to younger high-risk women, whose breasts are more likely to be dense.

MRI is not simply 'better' in every way, though. It can sometimes flag areas that turn out to be harmless, leading to further tests or short-term worry, and it cannot pick up tiny specks of calcium (microcalcifications) as well as a mammogram can. That is why, for some women, the NHS offers MRI and mammography together, so the two tests complement each other. You can read more about the strengths and limits of mammograms in our guide on mammogram limitations and accuracy.

Who is offered breast MRI on the NHS?

Breast MRI surveillance is offered through the NHS to women who are at high risk of breast cancer. According to NHS guidance and NICE, the women who may be offered MRI screening include those who:

• Carry a known altered (faulty) gene that raises breast cancer risk, such as BRCA1, BRCA2, PALB2 or TP53.
• Have not been tested themselves but have a high chance of carrying such a gene because of a strong family history.
• Have a high lifetime risk of breast cancer worked out from their family history, even without a known faulty gene.
• Had radiotherapy to the chest area when they were young, for example to treat Hodgkin lymphoma.

The NHS runs a separate surveillance programme for women at very high risk. According to GOV.UK guidance, this programme is for women with a lifetime breast cancer risk of around 40% or greater, usually because of a proven genetic cause in themselves or their family. Eligibility is decided through your GP, a family history clinic or a genetics service, not by self-referral, so the first step is always a conversation with a health professional who can assess your risk.

MRI for BRCA carriers and inherited risk

BRCA1 and BRCA2 are genes that everyone has. When one of them carries a fault, it raises the risk of breast and ovarian cancer, often at a younger age than usual. Because of this, women who carry a faulty BRCA gene, or who have a high chance of carrying one, are offered extra screening that starts earlier and includes MRI.

According to NICE guidance on familial breast cancer, women with a known or likely faulty BRCA1 or BRCA2 gene are generally offered yearly MRI from the age of 30 to 49, with yearly mammograms added from around age 40. This reflects the fact that MRI is especially valuable in the younger years, when breasts tend to be denser and mammograms less reliable. From age 50, screening is usually reviewed and tends to move towards yearly mammograms, with MRI continued only if the breasts are shown to be dense.

For women with a faulty TP53 gene, or a high chance of carrying one (linked to a rare condition called Li-Fraumeni syndrome), MRI is recommended even earlier, from around age 20, and NICE advises that mammograms are not offered to TP53 carriers because of their particular sensitivity to radiation. Your genetics team will explain exactly what is recommended for your specific gene and age. To understand inherited risk in more depth, see our guide on breast cancer genes and family history.

MRI, dense breasts and younger women

Breasts are made of fatty tissue and glandular tissue. 'Dense' breasts have proportionally more glandular tissue, which looks white on a mammogram, the same colour as many cancers. This can make a small cancer harder to see, a bit like spotting a snowflake against a white sky. Dense breasts are more common in younger women and are not something you can feel or that means anything is wrong.

Because MRI does not rely on X-rays and is not affected by density in the same way, it can be a useful extra test for some women with very dense breasts who are also at increased risk. According to NICE, MRI is not offered to women simply because they have dense breasts, however. It is recommended based on overall risk, such as a strong family history or a known genetic fault, rather than on density alone. If you have been told your breasts are dense, our guide on dense breasts and breast cancer explains what this does and does not mean.

This combination of factors, younger age, denser breasts and higher inherited risk, is exactly why MRI plays a bigger role for women under 50 who are being watched closely. The standard NHS screening programme does not routinely invite women in this age group, so high-risk younger women are looked after through these specialist surveillance arrangements instead. Our guide on breast cancer in young women covers this stage of life in more detail.

What happens during a breast MRI

Knowing what to expect can take away a lot of the worry. According to the NHS, a breast MRI is painless, although the scanner is noisy and you need to keep still. Here is what usually happens:

• You will be asked about any metal in your body, such as a pacemaker or certain implants, as the strong magnet means MRI is not safe for everyone.
• If contrast dye is being used, a small needle (cannula) is placed in your arm or hand.
• You lie face down with your breasts positioned in cushioned openings, and the table moves into the scanner tunnel.
• The scan usually takes around 30 to 45 minutes, and you will hear loud tapping and humming, so you may be offered earplugs or headphones.
• You can usually talk to the staff through an intercom and hold a buzzer to let them know if you need anything.

Results are not given on the day. A specialist doctor reviews the images and sends a report to the team looking after you, who will be in touch. If something needs a closer look, you may be asked back for more tests, such as an ultrasound or a small sample (biopsy). Being recalled is common and does not mean you have cancer, but it is natural to feel anxious while you wait, and your breast care team can support you through it.

Screening, early detection and fair access

Finding breast cancer early gives the best chance of successful treatment. According to the World Health Organization, mortality is reduced when breast cancer is detected and treated early, which is why early detection and timely, effective treatment are so important. Targeted tools like MRI surveillance allow the NHS to keep a closer eye on women who need it most, during the years when their risk is highest.

Even within the UK, not everyone finds it equally easy to take up screening or to reach a family history or genetics clinic. Practical barriers, such as travel, time off work, language or simply not knowing that extra screening exists, can mean some high-risk women miss out on early detection. Part of our charity's mission is to support early detection and fairer access to breast care in underserved communities, so that more women can benefit from the kind of monitoring described here. If you think your family history might put you at higher risk, the most important step is to talk to your GP, who can refer you for assessment.